Literature DB >> 20458315

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium.

Frank Dieterle1, Frank Sistare, Federico Goodsaid, Marisa Papaluca, Josef S Ozer, Craig P Webb, William Baer, Anthony Senagore, Matthew J Schipper, Jacky Vonderscher, Stefan Sultana, David L Gerhold, Jonathan A Phillips, Gérard Maurer, Kevin Carl, David Laurie, Ernie Harpur, Manisha Sonee, Daniela Ennulat, Dan Holder, Dina Andrews-Cleavenger, Yi-Zhong Gu, Karol L Thompson, Peter L Goering, Jean-Marc Vidal, Eric Abadie, Romaldas Maciulaitis, David Jacobson-Kram, Albert F Defelice, Elizabeth A Hausner, Melanie Blank, Aliza Thompson, Patricia Harlow, Douglas Throckmorton, Shen Xiao, Nancy Xu, William Taylor, Spiros Vamvakas, Bruno Flamion, Beatriz Silva Lima, Peter Kasper, Markku Pasanen, Krishna Prasad, Sean Troth, Denise Bounous, Denise Robinson-Gravatt, Graham Betton, Myrtle A Davis, Jackie Akunda, James Eric McDuffie, Laura Suter, Leslie Obert, Magalie Guffroy, Mark Pinches, Supriya Jayadev, Eric A Blomme, Sven A Beushausen, Valérie G Barlow, Nathaniel Collins, Jeff Waring, David Honor, Sandra Snook, Jinhe Lee, Phil Rossi, Elizabeth Walker, William Mattes.   

Abstract

The first formal qualification of safety biomarkers for regulatory decision making marks a milestone in the application of biomarkers to drug development. Following submission of drug toxicity studies and analyses of biomarker performance to the Food and Drug Administration (FDA) and European Medicines Agency (EMEA) by the Predictive Safety Testing Consortium's (PSTC) Nephrotoxicity Working Group, seven renal safety biomarkers have been qualified for limited use in nonclinical and clinical drug development to help guide safety assessments. This was a pilot process, and the experience gained will both facilitate better understanding of how the qualification process will probably evolve and clarify the minimal requirements necessary to evaluate the performance of biomarkers of organ injury within specific contexts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458315     DOI: 10.1038/nbt.1625

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  11 in total

1.  Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.

Authors:  Frank Dieterle; Elias Perentes; André Cordier; Daniel R Roth; Pablo Verdes; Olivier Grenet; Serafino Pantano; Pierre Moulin; Daniel Wahl; Andreas Mahl; Peter End; Frank Staedtler; François Legay; Kevin Carl; David Laurie; Salah-Dine Chibout; Jacky Vonderscher; Gérard Maurer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Next-generation biomarkers for detecting kidney toxicity.

Authors:  Joseph V Bonventre; Vishal S Vaidya; Robert Schmouder; Peter Feig; Frank Dieterle
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

3.  A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.

Authors:  Josef S Ozer; Frank Dieterle; Sean Troth; Elias Perentes; André Cordier; Pablo Verdes; Frank Staedtler; Andreas Mahl; Olivier Grenet; Daniel R Roth; Daniel Wahl; François Legay; Daniel Holder; Zoltan Erdos; Katerina Vlasakova; Hong Jin; Yan Yu; Nagaraja Muniappa; Tom Forest; Holly K Clouse; Spencer Reynolds; Wendy J Bailey; Douglas T Thudium; Michael J Topper; Thomas R Skopek; Joseph F Sina; Warren E Glaab; Jacky Vonderscher; Gérard Maurer; Salah-Dine Chibout; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

4.  Towards consensus practices to qualify safety biomarkers for use in early drug development.

Authors:  Frank D Sistare; Frank Dieterle; Sean Troth; Daniel J Holder; David Gerhold; Dina Andrews-Cleavenger; William Baer; Graham Betton; Denise Bounous; Kevin Carl; Nathaniel Collins; Peter Goering; Federico Goodsaid; Yi-Zhong Gu; Valerie Guilpin; Ernie Harpur; Alita Hassan; David Jacobson-Kram; Peter Kasper; David Laurie; Beatriz Silva Lima; Romaldas Maciulaitis; William Mattes; Gérard Maurer; Leslie Ann Obert; Josef Ozer; Marisa Papaluca-Amati; Jonathan A Phillips; Mark Pinches; Matthew J Schipper; Karol L Thompson; Spiros Vamvakas; Jean-Marc Vidal; Jacky Vonderscher; Elizabeth Walker; Craig Webb; Yan Yu
Journal:  Nat Biotechnol       Date:  2010-05-10       Impact factor: 54.908

5.  Evolution of biomarker qualification at the health authorities.

Authors:  Federico Goodsaid; Marisa Papaluca
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

6.  Fit-for-purpose method development and validation for successful biomarker measurement.

Authors:  Jean W Lee; Viswanath Devanarayan; Yu Chen Barrett; Russell Weiner; John Allinson; Scott Fountain; Stephen Keller; Ira Weinryb; Marie Green; Larry Duan; James A Rogers; Robert Millham; Peter J O'Brien; Jeff Sailstad; Masood Khan; Chad Ray; John A Wagner
Journal:  Pharm Res       Date:  2006-01-12       Impact factor: 4.200

Review 7.  Biomarkers of acute renal injury and renal failure.

Authors:  Ronald J Trof; Francesco Di Maggio; Jan Leemreis; A B Johan Groeneveld
Journal:  Shock       Date:  2006-09       Impact factor: 3.454

8.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

9.  Urine biomarkers predict the cause of glomerular disease.

Authors:  Sanju A Varghese; T Brian Powell; Milos N Budisavljevic; Jim C Oates; John R Raymond; Jonas S Almeida; John M Arthur
Journal:  J Am Soc Nephrol       Date:  2007-02-14       Impact factor: 10.121

Review 10.  Disease-dependent mechanisms of albuminuria.

Authors:  Wayne D Comper; Lucinda M Hilliard; David J Nikolic-Paterson; Leileata M Russo
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-25
View more
  103 in total

1.  Next-generation biomarkers for detecting kidney toxicity.

Authors:  Joseph V Bonventre; Vishal S Vaidya; Robert Schmouder; Peter Feig; Frank Dieterle
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Towards consensus practices to qualify safety biomarkers for use in early drug development.

Authors:  Frank D Sistare; Frank Dieterle; Sean Troth; Daniel J Holder; David Gerhold; Dina Andrews-Cleavenger; William Baer; Graham Betton; Denise Bounous; Kevin Carl; Nathaniel Collins; Peter Goering; Federico Goodsaid; Yi-Zhong Gu; Valerie Guilpin; Ernie Harpur; Alita Hassan; David Jacobson-Kram; Peter Kasper; David Laurie; Beatriz Silva Lima; Romaldas Maciulaitis; William Mattes; Gérard Maurer; Leslie Ann Obert; Josef Ozer; Marisa Papaluca-Amati; Jonathan A Phillips; Mark Pinches; Matthew J Schipper; Karol L Thompson; Spiros Vamvakas; Jean-Marc Vidal; Jacky Vonderscher; Elizabeth Walker; Craig Webb; Yan Yu
Journal:  Nat Biotechnol       Date:  2010-05-10       Impact factor: 54.908

3.  A roadmap for biomarker qualification.

Authors:  David G Warnock; Carl C Peck
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

4.  Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.

Authors:  Chirag R Parikh; Steven G Coca; Heather Thiessen-Philbrook; Michael G Shlipak; Jay L Koyner; Zhu Wang; Charles L Edelstein; Prasad Devarajan; Uptal D Patel; Michael Zappitelli; Catherine D Krawczeski; Cary S Passik; Madhav Swaminathan; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 10.121

Review 5.  A basic science view of acute kidney injury biomarkers.

Authors:  Jennifer R Charlton; Didier Portilla; Mark D Okusa
Journal:  Nephrol Dial Transplant       Date:  2014-01-02       Impact factor: 5.992

6.  Effects of General Anesthesia on 2 Urinary Biomarkers of Kidney Injury-Hepatitis A Virus Cellular Receptor 1 and Lipocalin 2-in Male C57BL/6J Mice.

Authors:  Krista M Gibbs; Jenelle M Izer; W Brian Reeves; Ronald P Wilson; Timothy K Cooper
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-12-11       Impact factor: 1.232

Review 7.  Advances in predictive in vitro models of drug-induced nephrotoxicity.

Authors:  Joanne Y-C Soo; Jitske Jansen; Rosalinde Masereeuw; Melissa H Little
Journal:  Nat Rev Nephrol       Date:  2018-06       Impact factor: 28.314

8.  Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study.

Authors:  Laura Suter-Dick; L Mauch; D Ramp; M Caj; M K Vormann; S Hutter; H L Lanz; J Vriend; R Masereeuw; M J Wilmer
Journal:  AAPS J       Date:  2018-07-23       Impact factor: 4.009

9.  Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.

Authors:  Qin Zhang; Kelly J Davis; Dana Hoffmann; Vishal S Vaidya; Ronald P Brown; Peter L Goering
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 10.  Biomarkers in nephrology: Core Curriculum 2013.

Authors:  Gearoid M McMahon; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2013-02-27       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.